JWH 071 is primarily researched for its interaction with cannabinoid receptors, particularly CB1 and CB2, which are part of the endocannabinoid system in the human body. Its application is largely confined to scientific studies aimed at understanding the pharmacological effects of synthetic cannabinoids. Researchers utilize JWH 071 to explore its binding affinity and activation patterns with cannabinoid receptors, which can provide insights into the development of therapeutic agents targeting pain, inflammation, and neurological disorders. Additionally, it is used in forensic and toxicological studies to identify and understand the effects of synthetic cannabinoids in cases of substance abuse or overdose. However, it is not approved for medical or recreational use due to its potential for adverse effects and lack of comprehensive safety data.